Cost consequence analysis of Sitagliptin+Metformin vs Sulfonylureas+Metformin in type 2 diabetic patients in Italy Apre una nuova scheda del browser
(2016)
Inizio contenuto principale del sito
(2016)
(2016)
(2016)
(2016)
(2016)
(2016)
(2016)
(2016)
(2016)
(2016)